![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/05/29/2890252/0/en/scPharmaceuticals-to-Present-at-the-Jefferies-Global-Healthcare-Conference.html
https://www.globenewswire.com/news-release/2024/05/14/2881834/0/en/scPharmaceuticals-Inc-Reports-First-Quarter-2024-Financial-Results-and-Provides-Business-Update.html
https://www.globenewswire.com/news-release/2024/05/13/2880871/0/en/scPharmaceuticals-to-Present-at-the-H-C-Wainwright-2nd-Annual-BioConnect-Investor-Conference.html
https://www.globenewswire.com/news-release/2024/05/07/2877193/0/en/scPharmaceuticals-to-Announce-First-Quarter-2024-Financial-Results-on-Tuesday-May-14-2024.html
https://www.globenewswire.com/news-release/2024/04/24/2868561/0/en/scPharmaceuticals-Announces-First-Participant-Enrolled-in-Pivotal-Pharmacokinetic-Study-of-FUROSCIX-Auto-Injector-furosemide-80mg-mL-Injection.html
https://www.globenewswire.com//news-release/2024/03/13/2845823/0/en/scPharmaceuticals-Inc-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Provides-Business-Update.html
https://www.globenewswire.com//news-release/2024/03/06/2841762/0/en/scPharmaceuticals-to-Announce-Fourth-Quarter-and-Full-Year-2023-Financial-Results-on-Wednesday-March-13-2024.html
https://www.globenewswire.com//news-release/2024/02/28/2837392/0/en/scPharmaceuticals-to-Participate-in-Two-Upcoming-Investor-Conferences.html
https://www.globenewswire.com//news-release/2024/01/04/2804315/0/en/scPharmaceuticals-Announces-Preliminary-Unaudited-Q4-and-Full-Year-2023-Net-FUROSCIX-Revenue.html
https://www.globenewswire.com//news-release/2023/11/08/2776650/0/en/scPharmaceuticals-Inc-Reports-Third-Quarter-2023-Financial-Results-and-Provides-Business-Update.html